Yes. This is a game changer. Beyond being able to replace AVS, it allows one to “see” the underlying pathological contributors to a large proportion of “idiopathic” hypertension. This is another piece of evidence that should make clinicians rethink the pathogenesis and treatment of hypertension

Interesting company choice, but I'm glad its not gone entirely. Thanks for the insight!

So they didn't discontinue Bimagrumab?

Which makes it even worse one cannot attend online 😔

FINE-ONE (Finerenone in albuminuric T1DM) results should be out soon/will be presented at ASN kidney week :)

I think I'm speaking for a lot of people here when I say it would be much appreciated if you post it on bluesky simultaneously.

Ein Held meiner Kindheit, nebst Mira Lobe, Astrid Lindgren, Janosch und dem immer noch innig geliebten Erwin Moser.

Excellent decision, easy to remember, imho. Although I'd much rather be in a Sean Connery than in a Roger Moore trial ;-)

Yes, absolutely, aiming to phase out insulin as soon as possible.

I tend to use basal insulin a lot (mostly after Metformin, SGLT2i and Incretin-based), for reaching a1c goals.

Das Museum der Kunst der Verlorenen Generation in Salzburg empfehle ich jedem Besucher.